Recent News

• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Cantor Global Healthcare Conference
• 09.03.2025 - Cantor Global Healthcare Conference
• 08.29.2025 - Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
• 08.29.2025 - Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
• 08.29.2025 - Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias
• 08.26.2025 - Esperion to Participate in Upcoming September Investor Conferences
• 08.26.2025 - Esperion to Participate in Upcoming September Investor Conferences
• 08.26.2025 - Esperion to Participate in Upcoming September Investor Conferences

Recent Filings

• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.11.2025 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
• 08.11.2025 - 8-K/A Current report